- Home
- MGLD vs CRVO Comparison
MGLD vs CRVO Comparison
Compare MGLD & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGLD | CRVO |
|---|---|---|
| Founded | 1996 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.8M | 47.7M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | MGLD | CRVO |
|---|---|---|
| Price | $1.20 | $3.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 13.6K | ★ 68.3K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,876,734.00 | $4,006,510.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.64 | $3.51 |
| 52 Week High | $1.38 | $13.13 |
Technical Indicators
Market Signals| Indicator | MGLD | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 44.89 |
| Support Level | $0.86 | $3.58 |
| Resistance Level | $1.36 | $5.24 |
| Average True Range (ATR) | 0.08 | 0.33 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 39.28 | 47.06 |
Price Performance
Historical ComparisonAbout MGLD The Marygold Companies Inc.
The Marygold Companies Inc is an international holding company focused on acquiring and growing profitable businesses. Its main segments include U.S. Fund Management through USCF Investments, Food Products via Gourmet Foods and Printstock Products in New Zealand, Beauty Products under the Original Sprout brand, and formerly Security Systems through Brigadier, sold in 2025. The majority of revenue comes from fund management. The company operates in the USA, New Zealand, the United Kingdom, and Canada, with the majority of revenue generated from the USA. Its business approach focuses on strengthening financial services, expanding fintech, and managing a diverse portfolio for growth.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.